ATG7 and breast cancer: Atg7f/f;Wap-Cre (Atg7-CKO) mice had slightly shorter overall survival (T50 = 604 days) (Fig 1A); 1 of the 22 mice (4.5%) developed mammary tumor and 9 (45.5%) developed other tumors (Fig 1C).